Dianthus Therapeutics Q3 EPS $(0.81) Beats $(0.97) Estimate, Sales $1.210M vs $396K YoY

Benzinga · 19h ago
Dianthus Therapeutics (NASDAQ:DNTH) reported quarterly losses of $(0.81) per share which beat the analyst consensus estimate of $(0.97) by 16.49 percent. This is a 16.49 percent increase over losses of $(0.97) per share from the same period last year. The company reported quarterly sales of $1.210 million which beat the analyst consensus estimate of $444.643 thousand by 172.13 percent. This is a 205.56 percent increase over sales of $396.000 thousand the same period last year.